ceric oxide has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Wahab, Z; Chhina, J; Dar, S; Das, S; Giri, S; Gupta, A; Hijaz, M; Mert, I; Munkarah, A; Rattan, R; Seal, S; Tebbe, C | 1 |
| Lord, MS; Vassie, JA; Whitelock, JM | 1 |
| Giri, S; Graham, RP; Karakoti, A; Maguire, JL; Rattan, R; Reilly, CM; Seal, S; Shridhar, V | 1 |
3 other study(ies) available for ceric oxide and Ovarian Neoplasms
| Article | Year |
|---|---|
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerium; Cisplatin; Female; Folate Receptor 1; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Mice; Nanoparticles; Neovascularization, Pathologic; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Endocytosis of cerium oxide nanoparticles and modulation of reactive oxygen species in human ovarian and colon cancer cells.
Topics: Biological Transport, Active; Caveolae; Cell Line, Tumor; Cell Proliferation; Cerium; Colonic Neoplasms; Cytoplasm; Endocytosis; Female; Free Radical Scavengers; Humans; Lysosomes; Male; Nanoparticles; Ovarian Neoplasms; Reactive Oxygen Species | 2017 |
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cerium; Disease Models, Animal; Endothelial Cells; Female; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Reactive Oxygen Species; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factors | 2013 |